- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04352478
Incidental Cancer in Gallbladder Surgical Specimens Focus on Elderly Patients
April 20, 2020 updated by: Ufuk Uylas, Dr. Ersin Arslan Education and Training Hospital
Incidental Cancer in Gallbladder Surgical Specimens Focus on Elderly Patients, Retrospective Analysis of 2389 Patients
Causes such as long-term stones and polyp are thought to play a role in the etiology of gallbladder cancer.
The routine histopathological examination provides the detection of incidental gallbladder cancers.
It should be remembered that acute or chronic cholecystitis accompanied by the thicked wall and a prolonged history of gallstones may be the cause of malignancy, especially in elderly patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The investigators aimed to incidental gallbladder cancer and compare other pathology results with elderly patients.
Study Type
Observational
Enrollment (Actual)
2389
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Gaziantep, Turkey
- Dr. Ersin Arslan Training and Resource Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients who underwent cholecystectomy between January 2016 and February 2020 at our hospital
Description
Inclusion Criteria:
- acute cholecystectomy
- elective cholecystectomy
Exclusion Criteria:
- lack of data
- incidental cholecystectomy,
- cholecystectomy secondary to trauma
- cholecystectomy secondary to malignancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Elder
elderly (≥60 years old).
|
Incidental gallbladder cancer and other pathology
|
Young
young (<60 years old)
|
Incidental gallbladder cancer and other pathology
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of Incidental Cancer
Time Frame: 2 or 3 week
|
Number of Participants with adenocarcinom
|
2 or 3 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ufuk Uylas, Dr. Ersin Arslan Training and Resource Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 20, 2020
Primary Completion (Actual)
April 1, 2020
Study Completion (Actual)
April 13, 2020
Study Registration Dates
First Submitted
April 13, 2020
First Submitted That Met QC Criteria
April 15, 2020
First Posted (Actual)
April 20, 2020
Study Record Updates
Last Update Posted (Actual)
April 22, 2020
Last Update Submitted That Met QC Criteria
April 20, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 13042020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pathology
-
University of RochesterAmerican Orthopaedic Foot and Ankle SocietyCompleted
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Consorci Sanitari de TerrassaUnknownGynecological PathologySpain
-
University Hospital, Strasbourg, FranceUnknownRespiratory Pathology | Obstructive SyndromeFrance
-
University Hospital, MotolCompletedECMO Primary Hemostasis PathologyCzechia
-
Dr. Ersin Arslan Education and Training HospitalCompleted
-
Arthrex, Inc.RecruitingDegenerative and Traumatic Pathology of the Knee | Degenerative and Traumatic Pathology of the Shoulder and Elbow | Degenerative and Traumatic Pathology of the Foot and Ankle | Degenerative and Traumatic Pathology of the Hand and Wrist | Degenerative and Traumatic Pathology of the HipUnited States, United Kingdom, Canada, Puerto Rico, South Africa
-
Rigshospitalet, DenmarkCompleted
-
Hamamatsu Photonics K.K.Completed
-
Uelk, J. Daniel, D.O.Unknown
Clinical Trials on Histopathological result
-
University Hospital Inselspital, BerneCompletedNeuroendocrine Tumors of the AppendixSwitzerland
-
Geisinger ClinicNational Human Genome Research Institute (NHGRI)Active, not recruitingLynch Syndrome | Familial Hypercholesterolemia | Hereditary Breast and Ovarian Cancer SyndromeUnited States
-
Aga Khan University Hospital, PakistanCompletedBreast Cancer | Genetic Predisposition | BRCA Mutation | Occult CancerPakistan
-
Mersin UniversityCompleted
-
Dr. Ersin Arslan Education and Training HospitalCompleted
-
Yanqing LiUnknownEarly Detection of CancerChina
-
University of California, Los AngelesCompletedCOVID-19United States
-
Medical University of SilesiaCompleted
-
Lucid Diagnostics, Inc.Medex15Recruiting
-
VA Office of Research and DevelopmentEnrolling by invitationCardiovascular DiseaseUnited States